InvestorsHub Logo
Followers 1053
Posts 189434
Boards Moderated 1
Alias Born 06/19/2009

Re: None

Friday, 09/14/2018 7:22:26 PM

Friday, September 14, 2018 7:22:26 PM

Post# of 7536
Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First & Only Anti-CGRP Treatment with Both Quarter...


My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.